Metraipolis › archive › dc_ecaf1540a736

Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients — Europe PMC PMID:41021466

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41021466
DOI
10.1093/oncolo/oyaf323
License (as archived)
solo-consultazione
Archived
2026-11-09T16:19:58.104Z
SHA-256 of the archived text
c1f35c01e02725fff939f49af21e42c5df4827fd67187d7dac0c43b6bde6c0cf
Stable URL of this page
https://metraipolis.com/documento/dc_ecaf1540a736

How to cite

Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients — Europe PMC PMID:41021466 — Europe PMC (en), https://europepmc.org/article/MED/41021466 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ecaf1540a736 (Metraipolis archive dc_ecaf1540a736, sha256 c1f35c01e02725fff939f49af21e42c5df4827fd67187d7dac0c43b6bde6c0cf)
BibTeX
@misc{dcecaf1540a736,
  title = {Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients — Europe PMC PMID:41021466},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41021466},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ecaf1540a736; sha256 c1f35c01e02725fff939f49af21e42c5df4827fd67187d7dac0c43b6bde6c0cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41021466. Agents can read the archived copy with the MCP tool read_document.